Kunal Keskar

Kunal Keskar has worked in the field of research and medicinal chemistry since 2004. Kunal began their career as an Assistant Research Scientist at AstraZeneca, where they worked on the development of antituberculosis drugs. In 2010, they moved to McMaster University, where they served as a Postdoctoral Researcher and Teaching Assistant. In 2015, they continued their postdoctoral work at the University of Toronto. In 2017, they transitioned to Appili Therapeutics as a Medicinal Chemist. Currently, they are employed as a Research Scientist II at Treventis Corporation.

Kunal Keskar completed their B.Sc. in Chemistry from Shivaji University between 1999 and 2002. Kunal then went on to receive their M.S. in Organic Chemistry from Savitribai Phule Pune University between 2002 and 2004. Kunal then pursued their Doctor of Philosophy (PhD) in Organic Chemistry from McMaster University between 2010 and 2014. After that, they completed their Postdoctoral Studies in Medicinal Chemistry from the University of Toronto between 2015 and 2017.